GlassScriptPhysician profile
Michael A Connors
NPI 1386266690
$1,458.90
in general payments reported to CMS, 2019-2025
16 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.00 · 2023: $647 · 2024: $440 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $231.36 | 2022-2023 | Xeomin |
| Angiodynamics, INC. | $172.04 | 2024 | Auryon Laser System 100-120 Vac |
| Biotronik Nro, INC. | $165.97 | 2025 | Prospera |
| Averitas Pharma INC. | $138.28 | 2024-2025 | Qutenza |
| Medtronic, INC. | $134.24 | 2023 | Intellis Adaptivestim |
| Curonix LLC | $126.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $106.33 | 2023 | Diamondback Peripheral |
| Abbvie INC. | $90.07 | 2022-2024 | Botox |
| Ipsen Biopharmaceuticals, INC | $78.32 | 2025 | Dysport, Iqirvo |
| Avanos Medical | $68.17 | 2024 | Coolief* Cooled Radiofrequency |
| Spr Therapeutics, INC | $49.14 | 2023 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $23.41 | 2024 | Iovera |
| Convatec INC. | $21.79 | 2024 | |
| Azurity Pharmaceuticals, INC. | $20.96 | 2023 | Horizant |
| Boston Scientific Corporation | $16.97 | 2024 | Ekosonic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Connors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.